Qiaoying Lv

Qiaoying Lv

Auto-generated profile, based on publicly available information

Qiaoying Lv

Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2019 in Human Cell
Verified
Journal Article
Closed access
PDF file
LWLi Wang
Li Wang
QLQiaoying Lv
Qiaoying Lv
XSXicheng Song
Xicheng Song
KJKun Jiang
Kun Jiang
JZJunhong Zhang
Junhong Zhang

10 March 2023 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
YXYu Xue
Yu Xue
YDYouting Dong
Youting Dong
YLYaochen Lou
Yaochen Lou
QLQiaoying Lv
Qiaoying Lv
WSWeiwei Shan
Weiwei Shan
XCXiaojun Chen
Xiaojun Chen
Xue Y, et al. J Gynecol Oncol. 2023 Mar;34:e53. https://doi.org/10.3802/jgo.2023.34.e53

1 January 2021 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
LWLulu Wang
Lulu Wang
XLXueZhen Luo
XueZhen Luo
QWQian Wang
Qian Wang
QLQiaoying Lv
Qiaoying Lv
PWPengfei Wu
Pengfei Wu
XCXiaojun Chen
Xiaojun Chen
Wang L, et al. J Gynecol Oncol. 2021 May;32(5):e70. https://doi.org/10.3802/jgo.2021.32.e70

15 May 2024 in Cancer Immunology Research
Verified
Journal Article
Closed access
QLQiaoying Lv
Qiaoying Lv
TSTong Su
Tong Su
WLWei Liu
Wei Liu
LWLulu Wang
Lulu Wang
JHJiali Hu
Jiali Hu
XCXiaojun Chen
Xiaojun Chen
An immunosuppressive microenvironment promotes the occurrence and development of tumors. Low apolipoprotein A1 (ApoA1) is closely related to tumor development, but the underlying mechanisms are unclear. This study investigated the association between serum ApoA1 levels and the immune microenvironment in endometrial, ovarian, and lung cancers. The serum ApoA1 level was decreased significantly in patients with endometrial and ovarian cancers compared with healthy controls. In endometrial cancer (EC) tissues, the low serum ApoA1 level group showed increased CD163+ macrophage infiltration and decreased CD8+ T-cell infiltration compared with the normal serum ApoA1 group. Compromised tumor-infiltrating CD8+ T-cell functions and decreased CD8+ T-cell infiltration also were found in tumor-bearing Apo1-knockout mice. CD8+ T-cell depletion experiments confirmed that ApoA1 exerted its antitumor activity in a CD8+ T-cell–dependent manner. In vitro experiments showed that the ApoA1 mimetic peptide L-4F directly potentiated the antitumor activity of CD8+ T cells via a HIF-1α–mediated glycolysis pathway. Mechanistically, ApoA1 suppressed ubiquitin-mediated degradation of HIF-1α protein by downregulating HIF-1α subunit α inhibitor. This regulatory process maintained the stability of HIF-1α protein and activated the HIF-1α signaling pathway. Tumor-bearing Apoa1 transgenic mice showed an increased response to anti–PD-1 therapy, leading to reduced tumor growth along with increased infiltration of activated CD8+ T cells and enhanced tumor necrosis. The data reported herein demonstrate critical roles for ApoA1 in enhancing CD8+ T-cell immune functions via HIF-1α–mediated glycolysis and support clinical investigation of combining ApoA1 supplementation with anti–PD-1 therapy for treating cancer.

1 January 2019 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
TKTae-Wook Kong
Tae-Wook Kong
HRHee-Sug Ryu
Hee-Sug Ryu
SKSeung Cheol Kim
Seung Cheol Kim
TETakayuki Enomoto
Takayuki Enomoto
JLJin Li
Jin Li
SJSeob Jeon
Seob Jeon
Kong TW, et al. J Gynecol Oncol. 2018 Aug;30:e39. https://doi.org/10.3802/jgo.2019.30.e39

6 April 2022 in Cancer Gene Therapy
Verified
Journal Article
Open access
PDF file
YCYali Cheng
Yali Cheng
LXLiying Xie
Liying Xie
ZXZhiying Xu
Zhiying Xu
MHMengxin Hao
Mengxin Hao
BYBingyi Yang
Bingyi Yang
XCXiaojun Chen
Xiaojun Chen
Progestin is one of the main hormone treatment regimens for early-stage estrogen receptor- and progesterone receptor (PR)-positive endometrial cancer (EC). However, the response rate of EC to progestins is unsatisfactory. Investigating the mechanisms related to progestin treatment could help improve treatment efficacy. Studies have demonstrated that normal endometrial stromal cells (ESCs) increase the inhibitory effect of progestin on EC cell proliferation via paracrine signaling, but the mechanisms involved remain unclear. In this study, we found that ESCs had different morphological features between progestin-sensitive and -insensitive EC tissues. ESCs presented typical decidualization changes in progestin-sensitive cases, while they remained slim in progestin-insensitive EC lesions, indicating no response. Furthermore, ESCs enhanced the inhibitory effect of medroxyprogesterone acetate (MPA) on EC cell proliferation by secreting neuron cell adhesion molecule (NrCAM). MPA treatment enhanced NrCAM secretion by ESCs. EC xenografts in BALB/C nude mice demonstrated that MPA combined with NrCAM had an increased tumor inhibitory effect compared with MPA or NrCAM alone. Mechanistically, MPA upregulated NrCAM expression in ESCs through PR. Specifically, NrCAM increased PR expression in EC cells through TET1-induced hydroxymethylation of the PRB gene promoter region. These findings indicate that NrCAM or NrCAM combined with progestins could be a new EC treatment.